This file photo taken on April 8, 2020 shows one vial of the drug Remdesivir during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf in Hamburg, northern Germany, amidst the new coronavirus COVID-19 pandemic. Ulrich Perrey / POOL / AFP, the first drug to be shown to be relatively effective in treating COVID-19, and of which the United States has bought almost all supply.
President Donald Trump “has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” said Secretary of Health and Human Services Alex Azar. Washington’s buy-up raised concerns about a shortage in the rest of the world, but at least two European countries said Thursday that they were not worried.
In Germany, a health ministry spokesman said “the government secured stocks of remdesivir early on for the treatment of corona patients. At the moment, there are sufficient reserves.”